News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
316,830 Results
Type
Article (29186)
Company Profile (53)
Press Release (287585)
Multimedia
Podcasts (73)
Webinars (12)
Section
Business (86277)
Career Advice (877)
Deals (11091)
Drug Delivery (77)
Drug Development (46405)
Employer Resources (79)
FDA (7095)
Job Trends (6976)
News (142335)
Policy (14443)
Tag
2025 Best Places to Work (9)
2026 Best Places to Work (11)
2027 BioCapital Standard (3)
2027 BioMidwest Standard (1)
2027 Biotech Bay Standard (1)
2027 Biotech Beach Standard (3)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
40 Under 40 (2)
Academia (2260)
Accelerated approval (38)
ADA (26)
Adcomms (23)
Allergies (99)
Alliances (24290)
ALS (152)
Alzheimer's disease (1178)
Antibody-drug conjugate (ADC) (397)
Approvals (7530)
Artificial intelligence (566)
ASCO (180)
Autoimmune disease (288)
Automation (35)
Bankruptcy (83)
Belgium (20)
Best Places to Work (6072)
BIO (35)
Biologics (66)
BIOSECURE Act (16)
Biosimilars (118)
BioSpace Insights (69)
Biotechnology (41)
Bispecific (36)
Bladder cancer (136)
Brain cancer (58)
Breast cancer (592)
Cancer (4446)
Cardiovascular disease (257)
Career advice (748)
Career pathing (18)
CAR-T (251)
CDC (78)
CDMO (110)
Celiac Disease (1)
Cell-line development (1)
Cell therapy (640)
Cervical cancer (44)
Clinical research (39615)
Collaboration (1480)
Commercialization (28)
Company closure (4)
Compensation (225)
Complete response letters (32)
COVID-19 (2691)
CRISPR (122)
CRO (4)
C-suite (721)
Cystic fibrosis (103)
Data (6296)
Decentralized trials (2)
Denatured (11)
Depression (79)
Dermatology (115)
Diabetes (341)
Diagnostics (3125)
Digital health (31)
Diversity (6)
Diversity, equity & inclusion (20)
Drug discovery (279)
Drug pricing (81)
Drug shortages (9)
Duchenne muscular dystrophy (154)
Earnings (26091)
Editorial (44)
Employer branding (9)
Employer resources (75)
ESMO (242)
Events (44017)
Executive appointments (565)
Eye disease (16)
FDA (9585)
Fibrodysplasia Ossificans Progressiva (13)
Fragile X (4)
Friedreich's ataxia (23)
Frontotemporal dementia (25)
Funding (1335)
Gene editing (223)
Generative AI (52)
Gene therapy (533)
GLP-1 (466)
Government (3367)
Grass and pollen (3)
Guidances (188)
Healthcare (8805)
Hematology (119)
HIV (70)
Huntington's disease (35)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (73)
Immunology and inflammation (149)
Immuno-oncology (96)
Indications (165)
Infectious disease (3077)
Inflammatory bowel disease (161)
Inflation Reduction Act (7)
Influenza (155)
Intellectual property (151)
Interviews (122)
IPO (5345)
IRA (26)
Job creations (1162)
Job search strategy (644)
JPM (20)
Kidney cancer (14)
Kidney disease (85)
Labor market (45)
Layoffs (225)
Leadership (17)
Legal (2184)
Licensing (67)
Liver cancer (46)
Longevity (30)
Lung cancer (552)
Lung diease (14)
Lymphoma (300)
Machine learning (39)
Management (32)
Manufacturing (634)
Marketing (22)
MASH (106)
Medical affairs (4)
Medical device (4399)
Medtech (4467)
Melanoma (122)
Mergers & acquisitions (6413)
Metabolic disorders (804)
Middle East (1)
mRNA (282)
Multiple sclerosis (155)
Multispecific (4)
NASH (8)
Netherlands (14)
Neurodegenerative disease (290)
Neuropsychiatric disorders (41)
Neuroscience (2196)
Neurotech (3)
NextGen: Class of 2026 (2695)
Non-profit (2558)
Now hiring (20)
Obesity (332)
Opinion (170)
Ovarian cancer (191)
Pain (138)
Pancreatic cancer (249)
Parkinson's disease (240)
Partnered (20)
Patents (331)
Patient advocacy (3)
Patient recruitment (511)
Patient selection (75)
Peanut (28)
People (27242)
Peptides (33)
Pharmaceutical (15)
Pharmacy benefit managers (12)
Phase 1 (14848)
Phase 2 (17007)
Phase 3 (11748)
Pipeline (7464)
Policy (240)
Postmarket research (1313)
Preclinical (6799)
Press Release (43)
Prostate cancer (224)
Psychedelics (50)
Radioligand (2)
Radiopharmaceuticals (177)
Rare diseases (731)
Real estate (2189)
Recruiting (35)
Regenerative medicine (26)
Regulatory (12750)
Reports (26)
Research institute (2305)
Resumes & cover letters (167)
Rett syndrome (28)
RNA editing (26)
RSV (95)
Saudi Arabia (1)
Schizophrenia (82)
Series A (212)
Series B (141)
Service/supplier (1)
Sickle cell disease (79)
Special edition (6)
Spinal muscular atrophy (100)
Sponsored (27)
Startups (1900)
Stem cells (7)
Stomach cancer (6)
Substance use disorders (14)
Supply chain (68)
Switzerland (13)
Tariffs (36)
Tax incentives (1)
The Weekly (60)
Vaccines (1449)
Venture capital (72)
Weight loss (151)
Wet AMD (7)
Women's health (66)
Worklife (6)
Date
Today (6)
Last 7 days (309)
Last 30 days (1677)
Last 365 days (14129)
2026 (13043)
2025 (13730)
2024 (16453)
2023 (18954)
2022 (25366)
2021 (27328)
2020 (24616)
2019 (19766)
2018 (15010)
2017 (14156)
2016 (13823)
2015 (16180)
2014 (12088)
2013 (10132)
2012 (10527)
2011 (11036)
2010 (9684)
Location
Africa (458)
Alabama (86)
Alaska (5)
Arizona (200)
Arkansas (8)
Asia (20669)
Australia (4125)
California (7124)
Canada (1748)
China (966)
Colorado (276)
Connecticut (365)
Delaware (275)
Europe (45239)
Florida (1204)
Georgia (272)
Hawaii (3)
Idaho (22)
Illinois (518)
India (74)
Indiana (285)
Iowa (19)
Japan (428)
Kansas (48)
Kentucky (32)
Louisiana (27)
Maine (16)
Maryland (1114)
Massachusetts (5514)
Michigan (120)
Minnesota (303)
Mississippi (2)
Missouri (89)
Montana (17)
Nebraska (14)
Nevada (58)
New Hampshire (27)
New Jersey (2350)
New Mexico (14)
New York (2146)
North Carolina (922)
North Dakota (12)
Northern California (3780)
Ohio (214)
Oklahoma (15)
Oregon (14)
Pennsylvania (1392)
Puerto Rico (11)
Rhode Island (39)
South America (493)
South Carolina (32)
Southern California (2794)
Tennessee (112)
Texas (1268)
United States (26663)
Utah (165)
Vermont (1)
Virginia (160)
Washington D.C. (51)
Washington State (716)
West Virginia (3)
Wisconsin (92)
Wyoming (3)
316,830 Results for "duke human vaccine institute".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Rare diseases
Amgen shores up Tavneos’ FDA defense with Duke data analysis
After the FDA flagged patient deaths linked to Amgen’s rare disease drug Tavneos and called for its voluntary removal, the pharma recruited an independent data analysis from Duke researchers to help build the case for the drug’s continued market approval.
June 12, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Akagera Medicines Receives $7.8 Million Grant Expansion to Advance Dendritic Cell-Targeted mRNA Tuberculosis Vaccine Toward First-in-Human Trial
November 18, 2026
·
4 min read
Earnings
Moderna enjoys stable vaccine sales thanks to global COVID uptake
While Moderna preps an entry to the oncology market next year with a personalized cancer vaccine, COVID sales are holding steady with several other vaccine launches underway around the world.
November 6, 2026
·
4 min read
·
Annalee Armstrong
Press Releases
Feinstein Institutes Researchers Release World’s First Map of Branches of the Human Vagus Nerve
October 23, 2026
·
6 min read
Press Releases
AI-Designed Universal Coronavirus Vaccine Clears First Human Trial
July 28, 2026
·
1 min read
Vaccines
Pfizer eyes Europe first for Lyme vaccine as prevalence rises in US
Since Pfizer already owns a tick-borne encephalitis franchise in Europe, the region is a natural first step for the pharma’s upcoming Lyme disease vaccine.
November 4, 2026
·
1 min read
·
Annalee Armstrong
Press Releases
Nuravax and Institute for Molecular Medicine Announce Publication of Phase 1 Results for AV-1959R Amyloid-Beta Vaccine
October 13, 2026
·
5 min read
Press Releases
MUSE Cells Now Available at Longevity Medical Institute®
As part of its Regenerative Neurology Program, Longevity Medical Institute® is making MUSE cell therapy available to select patients, using cells produced in-house at the Institute’s biotechnology laboratory.
September 18, 2026
·
1 min read
Earnings
GSK vaccine sales miss expectations amid falling demand from adults
With pressure on GSK’s vaccine business, analysts predict the U.K. pharma will face challenges as it prepares for the loss of exclusivity on a key product.
October 28, 2026
·
2 min read
·
Nick Paul Taylor
Cancer
Sellas’ cancer vaccine slashes death risk by 41% in late-stage AML study
Sellas Life Sciences’ investigational cancer vaccine prolonged median overall survival by over nine months compared to standard of care in a Phase 3 trial for difficult-to-treat acute myeloid leukemia.
November 17, 2026
·
2 min read
·
Gabrielle Masson
1 of 31,683
Next